DermTech, Inc. financial data

Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 15 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 505% % -46%
Quick Ratio 8% % -17%
Debt-to-equity 101% % 168%
Return On Equity -139% % -69%
Return On Assets -69% % -15%
Operating Margin -589% % 30%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34,623,443 shares 11%
Common Stock, Shares, Outstanding 34,962,994 shares 12%
Common Stock, Value, Issued $3,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 34,706,491 shares 14%
Weighted Average Number of Shares Outstanding, Diluted 34,706,491 shares 14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $15,664,000 USD 9.7%
Cost of Revenue $14,331,000 USD 1.4%
Research and Development Expense $14,096,000 USD -36%
Selling and Marketing Expense $37,395,000 USD -36%
General and Administrative Expense $42,044,000 USD 6.7%
Operating Income (Loss) $92,202,000 USD 23%
Nonoperating Income (Expense) $2,574,000 USD 18%
Net Income (Loss) Attributable to Parent $89,628,000 USD 24%
Earnings Per Share, Basic -3 USD/shares 32%
Earnings Per Share, Diluted -3 USD/shares 32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $27,579,000 USD -43%
Marketable Securities, Current $11,400,000 USD -80%
Accounts Receivable, after Allowance for Credit Loss, Current $2,497,000 USD -32%
Inventory, Net $831,000 USD -47%
Other Assets, Current $651,000 USD -1.4%
Assets, Current $44,199,000 USD -61%
Property, Plant and Equipment, Net $4,498,000 USD -28%
Operating Lease, Right-of-Use Asset $50,806,000 USD -7.3%
Assets $102,970,000 USD -42%
Accounts Payable, Current $1,913,000 USD 14%
Employee-related Liabilities, Current $5,248,000 USD -31%
Accrued Liabilities, Current $1,943,000 USD -60%
Contract with Customer, Liability, Current $203,000 USD -16%
Liabilities, Current $12,518,000 USD -22%
Operating Lease, Liability, Noncurrent $50,424,000 USD -6.1%
Liabilities $62,976,000 USD -9.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $184,000 USD
Retained Earnings (Accumulated Deficit) $443,945,000 USD -25%
Stockholders' Equity Attributable to Parent $39,994,000 USD -63%
Liabilities and Equity $102,970,000 USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $17,119,000 USD 22%
Net Cash Provided by (Used in) Financing Activities $122,000 USD -87%
Net Cash Provided by (Used in) Investing Activities $7,834,000 USD
Common Stock, Shares Authorized 100,000,000 shares 100%
Common Stock, Shares, Issued 34,962,994 shares 12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9,163,000 USD 69%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,046,000 USD -40%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,000 USD 400%
Depreciation $490,000 USD 5.2%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $89,155,000 USD 24%
Property, Plant and Equipment, Gross $8,738,000 USD -9.8%
Operating Lease, Liability, Current $3,194,000 USD 82%
Share-based Payment Arrangement, Expense $16,526,000 USD -16%